Orphan Technologies Publishes Study Showing Prevalence of Classical Homocystinuria Substantially Higher than Previously Published Estimates

Orphan Technologies , a company dedicated to helping patients control their homocysteine levels, published study showing that 12,113 patients in the United States are diagnosed with classical homocystinuria (HCU) using strict ICD-10 diagnostic criteria in the U.S.